Leverage Shares 3x Long Moderna (MRNA) ETC (3MRE.L) Kursus
Leverage Shares 3x Long Moderna (MRNA) ETC Kursus
Aluseks
Leverage Shares 3x Long Moderna (MRNA) ETC pakub 3X igapäevast kokkupuudet MRNA-ga.
Leverage & Compounding Risk
This ETF rebalances daily to achieve its 3X target. Over periods longer than one day, compounding can cause returns to deviate significantly from 3X the underlying's return — especially in volatile, sideways markets (volatility decay). This product is designed for short-term trading, not buy-and-hold investing.
Leverage Shares 3x Long Moderna (MRNA) ETC hoiustuste loend
Korduma kippuvad küsimused Leverage Shares 3x Long Moderna (MRNA) ETC kohta
Leverage Shares 3x Long Moderna (MRNA) ETC pakub LeverageShares, mis on juhtiv tegija passiivsetesse investeeringutesse.
Leverage Shares 3x Long Moderna (MRNA) ETC ISIN on XS2675718725.
Leverage Shares 3x Long Moderna (MRNA) ETC aims to deliver 3 times the daily return of MRNA (long). The leverage resets each trading day, so multi-day returns can differ materially from 3X the underlying's cumulative return.
Volatility decay (also called compounding drag) occurs because Leverage Shares 3x Long Moderna (MRNA) ETC rebalances daily. In choppy, sideways markets the cumulative return can significantly trail 3X the underlying's period return — even if the underlying ends flat. The effect intensifies with higher leverage factors and longer holding periods.
Leveraged ETFs like Leverage Shares 3x Long Moderna (MRNA) ETC are designed for short-term, tactical trading — typically intraday or a few days. Holding them for weeks or months exposes investors to compounding risk and potential tracking deviation. Most issuers explicitly recommend against long-term holding.
Leverage Shares 3x Long Moderna (MRNA) ETC provides 3X daily long exposure to MRNA. When MRNA moves +1% in a day, Leverage Shares 3x Long Moderna (MRNA) ETC targets approximately 3% (before fees).
ETF noteeritakse valuutas EUR.
Euroopa investorid võivad kohata lisatasu valuutavahetuse ja tehingutasude eest.
Ei, Leverage Shares 3x Long Moderna (MRNA) ETC ei vasta EU UCITS investorite kaitse direktiividele.
Leverage Shares 3x Long Moderna (MRNA) ETC praegune keskmine kauplemismaht on 157 229,00.
Fond käivitati 15.12.2021-l.
Investeeringuid saab teha maaklerite või rahandusteaduste kaudu, mis pakuvad juurdepääsu ETF-de kauplemisele.
ETF-iga kaupeldakse börsil, sarnaselt aktsiatega.
Jah, ETF-i saab hoida tavalisel väärtpaberikontol.
ETF sobib nii lühiajaliste kui ka pikaajaliste investeerimisstrateegiate jaoks, sõltuvalt investori eesmärkidest.
ETF-i hinnatakse iga börsipäeva alusel.
Dividendide kohta teavet tuleks küsida pakkuja veebisaidilt või oma maaklerist.
Riskid hõlmavad turgu kõikumisi, valuutariske ja väiksemate ettevõtete riski.
ETF on kohustatud regulaarselt ja läbipaistvalt teatasele oma investeeringute kohta.
Jõudlust saab vaadata Eulerpool'il või otseselt pakkuja veebisaidil.
Lisateavet leiate pakkuja ametlikul veebisaidel.
ETF profiil
Leverage Shares 3x Long Moderna (MRNA) ETC